DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

ImmunoGen (NASDAQ: IMGN)

5.93 0.03 (0.51%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $5.93 0.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.90
Previous Close $5.90
Daily Range $5.81 - $6.03
52-Week Range $5.34 - $17.80
Market Cap $509.6M
P/E Ratio -6.15
Dividend (Yield) $0.00 (0.0%)
Volume 1,615,071
Average Daily Volume 1,802,808
Current FY EPS -$0.74

Sector

Healthcare

Industry

Drugs

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary

3 Value Stocks Near 52-Week Lows Worth Buying

These three value stocks have been beaten up recently, but there's a chance they may not stay near their 52-week lows for much longer.

13 Analyst Stocks at $10 and Under With Huge Implied Upside

ImmunoGen/Roche's Kadcyla Fails in Study, Shares Plunge - Analyst Blog

Roche Loses A Little Luster Before Year-End

Immunogen (IMGN) Showing Signs Of A Dead Cat Bounce Today

The 52-Week Low Club for Friday

Why ImmunoGen Inc. Stock Was Throttled

ImmunoGen shares lose half their value following an update on a key breast cancer drug trial. Find out whether today's swoon could mark a buying opportunity.

Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More

Mid-Day Losers From December 19: ImmunoGen, NQ Mobile And More

Top 3 Short Ideas Among Friday's Losers

See More IMGN News...

IMGN's Top Competitors

IMGN $5.93 (0.51%)
Current stock: IMGN
AMGN $163.46 (1.74%)
Current stock: AMGN
GILD $93.79 (2.74%)
Current stock: GILD
BIIB $342.40 (0.44%)
Current stock: BIIB